SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001012477-18-000033
Filing Date
2018-11-05
Accepted
2018-11-05 17:03:27
Documents
91
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q avdl2018q3.htm 10-Q 1879887
2 EXHIBIT 31.1 exhibit311q32018.htm EX-31.1 10344
3 EXHIBIT 31.2 exhibit312q32018.htm EX-31.2 10230
4 EXHIBIT 32.1 exhibit321q32018.htm EX-32.1 5723
5 EXHIBIT 32.2 exhibit322q32018.htm EX-32.2 5726
  Complete submission text file 0001012477-18-000033.txt   9064905

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT avdl-20180930.xml EX-101.INS 2207486
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT avdl-20180930.xsd EX-101.SCH 57090
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT avdl-20180930_cal.xml EX-101.CAL 119375
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT avdl-20180930_def.xml EX-101.DEF 220292
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT avdl-20180930_lab.xml EX-101.LAB 709431
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT avdl-20180930_pre.xml EX-101.PRE 417316
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Filer) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37977 | Film No.: 181160624
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences